Forian Inc. (NASDAQ:FORA – Get Free Report) shares were up 1% during mid-day trading on Tuesday . The company traded as high as $2.06 and last traded at $2.05. Approximately 4,898 shares traded hands during mid-day trading, a decline of 56% from the average daily volume of 11,125 shares. The stock had previously closed at $2.03.
Wall Street Analysts Forecast Growth
Separately, Roth Mkm reissued a “buy” rating and issued a $5.00 price target on shares of Forian in a research report on Thursday, November 14th.
View Our Latest Research Report on FORA
Forian Stock Up 1.0 %
Institutional Trading of Forian
A hedge fund recently bought a new stake in Forian stock. Caprock Group LLC bought a new stake in shares of Forian Inc. (NASDAQ:FORA – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 86,784 shares of the company’s stock, valued at approximately $230,000. Caprock Group LLC owned about 0.28% of Forian at the end of the most recent reporting period. 19.25% of the stock is owned by institutional investors and hedge funds.
Forian Company Profile
Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
Featured Stories
- Five stocks we like better than Forian
- What Are the FAANG Stocks and Are They Good Investments?
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Stock Analyst Ratings and Canadian Analyst Ratings
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Forian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forian and related companies with MarketBeat.com's FREE daily email newsletter.